Yahoo Finance

Gradient Denervation Technologies Announces Acceptance into FDA’s Total Product Life Cycle Advisory Program for Development of its Pulmonary Artery Denervation System

PARIS, June 18, 2025 (GLOBE NEWSWIRE) -- Gradient Denervation Technologies announced today that it has been accepted into the Total Product Life Cycle Advisory Program (TAP) Pilot from the U.S. Food ...
Yahoo Finance

Gradient Denervation Technologies Announces FDA Breakthrough Designation for Pulmonary Artery Denervation System

PARIS, May 19, 2025 (GLOBE NEWSWIRE) -- Gradient Denervation Technologies announced today the company’s pulmonary denervation system has received Breakthrough Device Designation by the U.S. Food and ...
Yahoo Finance

Gradient Denervation Technologies Appoints Stanton Rowe to Board of Directors and Receives FDA Approval to Expand Early Feasibility Study

PARIS, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Gradient Denervation Technologies, a Paris-based medical device company developing a minimally-invasive, ultrasound-based catheter system designed to treat ...
Finanznachrichten

Gradient Denervation Technologies Appoints Stanton Rowe to Board of Directors and Receives FDA Approval to Expand Early Feasibility Study

Serial entrepreneur and medical device industry executive adds key experience to board of directors PARIS, Oct. 22, 2024 (GLOBE NEWSWIRE) -- Gradient Denervation Technologies, a Paris-based medical ...